Lu-177-Rosopatamab
177Lu-Rosopatamab (177Lu-J591, 177Lu-TLX591, 177Lu-J591, 177Lu-ATL-101) is the Lutetium-177 labeled [...]
Lu-177-DOTAZOL
177Lu-DOTAZOL is a drug suitable for betatherapy of bone metastases [...]
Lu-177-IPN-01087
177Lu-IPN-01087 (177Lu-3BP-227) is a neurotensin antagonist peptide labeled with 177Lu [...]
Lu-177-Edotreotide (Solucin®)
177Lu-Edotreotide (177Lu--Octreotide, 177Lu-Solucin®) is a radiolabeled somatostatin analogue developed [...]
Lu-177-TLX250
177Lu-TLX250 (177Lu-Lutarex®, 177Lu-Girentuximab), a Lutetium-177-labeled monoclonal antibody is being developed [...]
Lu-177-Lilotomab Satetraxetan (Betalutin)
Betalutin™ is the brand name of an anti-CD37 antibody labeled [...]
Lu-177-FAP-2286
177Lu-FAP-2286 (177Lu-3BP-2286) is a molecule from the FAPi family [...]
Lu-177-FAPI-04
177Lu-FAPI-04 is the therapeutic analogue of the PET imaging agent [...]
Lu-177-iPSMA
177Lu-iPSMA is the therapeutic analogue of 99mTc-iPSMA developed at [...]
Lu-177-CTT-1403
177Lu-CTT1403 is the therapeutic analogue of 18F-CTT1057, a phosphoramide based [...]